[New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma].
Autor: | Minot-This MS; Institut Gustave-Roussy, Sorbonne Université, service d'oncologie digestive, 94800 Villejuif, France. Electronic address: ms.minot@gmail.com., Edeline J; Centre hospitalier universitaire de Rennes, centre Eugène-Marquis, service d'oncologie digestive, 35000 Rennes, France. |
---|---|
Jazyk: | francouzština |
Zdroj: | Bulletin du cancer [Bull Cancer] 2021 Feb; Vol. 108 (2), pp. 139-140. Date of Electronic Publication: 2021 Feb 02. |
DOI: | 10.1016/j.bulcan.2020.11.011 |
Databáze: | MEDLINE |
Externí odkaz: |